CLAYTON RUSSELL (Chief Medical Officer) received a stock award from LARIMAR THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/24/2025ACC: 0001062993-25-001079
Officer· Chief Medical Officer
Since Jan 2026
+163.14K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
163.14K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+23.31K
Price / share
—
Trade value
—
% of position
103.6%
1/22/2025
22.50K→45.81K
Total
Net shares
+23.31K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2025 | A · Award | +23.31K | — | — | 103.6% | 22.50K | 45.81K |
| Total | +23.31K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
139.84K shares
Shares
+139.84K
Strike price
3.46
Held after
139.84K
Exercisable
—
1/22/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock139.84K shares | 1/22/2025 | A · Award | +139.84K | 3.46 | — | 139.84K |